A detailed history of Morgan Stanley transactions in Genfit S.A. stock. As of the latest transaction made, Morgan Stanley holds 32,764 shares of GNFT stock, worth $180,529. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,764
Previous 28,464 15.11%
Holding current value
$180,529
Previous $101,000 16.83%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024

BUY
$3.41 - $5.92 $14,663 - $25,456
4,300 Added 15.11%
32,764 $118,000
Q2 2024

Aug 14, 2024

BUY
$3.41 - $5.92 $14,663 - $25,456
4,300 Added 15.11%
32,764 $118,000
Q1 2024

Oct 17, 2024

SELL
$3.34 - $4.04 $14,362 - $17,372
-4,300 Reduced 13.12%
28,464 $101,000
Q1 2024

Aug 16, 2024

SELL
$3.34 - $4.04 $7,678 - $9,287
-2,299 Reduced 7.47%
28,464 $101,000
Q1 2024

May 15, 2024

SELL
$3.34 - $4.04 $7,678 - $9,287
-2,299 Reduced 7.47%
28,464 $101,000
Q4 2023

Aug 16, 2024

SELL
$2.97 - $3.94 $5,942 - $7,883
-2,001 Reduced 6.11%
30,763 $118,000
Q4 2023

Feb 13, 2024

SELL
$2.97 - $3.94 $10,694 - $14,187
-3,601 Reduced 10.48%
30,763 $118,000
Q3 2023

Nov 15, 2023

SELL
$3.15 - $4.12 $16,695 - $21,836
-5,300 Reduced 13.36%
34,364 $112,000
Q2 2023

Aug 14, 2023

SELL
$3.54 - $4.68 $12,613 - $16,674
-3,563 Reduced 8.24%
39,664 $140,000
Q1 2023

May 15, 2023

SELL
$3.93 - $4.69 $19,932 - $23,787
-5,072 Reduced 10.5%
43,227 $177,000
Q4 2022

Feb 14, 2023

SELL
$3.53 - $4.39 $30,449 - $37,868
-8,626 Reduced 15.15%
48,299 $212,000
Q3 2022

Nov 14, 2022

BUY
$3.26 - $4.86 $16,828 - $25,087
5,162 Added 9.97%
56,925 $208,000
Q2 2022

Oct 27, 2022

SELL
$3.09 - $4.25 $74,672 - $102,705
-24,166 Reduced 31.83%
51,763 $166,000
Q2 2022

Aug 15, 2022

SELL
$3.09 - $4.25 $74,672 - $102,705
-24,166 Reduced 31.83%
51,763 $166,000
Q1 2022

Oct 27, 2022

BUY
$3.14 - $5.04 $75,881 - $121,796
24,166 Added 46.69%
75,929 $304,000
Q1 2022

May 13, 2022

SELL
$3.14 - $5.04 $10,362 - $16,632
-3,300 Reduced 4.17%
75,929 $304,000
Q4 2021

Feb 14, 2022

BUY
$3.01 - $5.65 $74,927 - $140,645
24,893 Added 45.81%
79,229 $396,000
Q3 2021

Nov 15, 2021

BUY
$3.58 - $4.14 $194,522 - $224,951
54,336 New
54,336 $201,000

Others Institutions Holding GNFT

About Genfit S.A.


  • Ticker GNFT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,815,500
  • Market Cap $274M
  • Description
  • Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...
More about GNFT
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.